FENC -49% on expected CRL due to CMC issues: https://www.globenewswire.com/news-release/2021/11/29/2341932/0/en/Fennec-Pharmaceuticals-Expects-to-Receive-Complete-Response-Letter-from-the-FDA-for-its-New-Drug-Application-for-PEDMARK-to-Prevent-Ototoxicity-Associated-with-Cisplatin-in-Pediatr.html